PL328228A1 - 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system - Google Patents

1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system

Info

Publication number
PL328228A1
PL328228A1 PL97328228A PL32822897A PL328228A1 PL 328228 A1 PL328228 A1 PL 328228A1 PL 97328228 A PL97328228 A PL 97328228A PL 32822897 A PL32822897 A PL 32822897A PL 328228 A1 PL328228 A1 PL 328228A1
Authority
PL
Poland
Prior art keywords
piperidines
indol
pyrazol
ethyl
nervous system
Prior art date
Application number
PL97328228A
Inventor
Henning Boettcher
Joachim Maerz
Gerd Bartoszyk
Hartmut Greiner
Juergen Harting
Christoph Seyfried
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL328228A1 publication Critical patent/PL328228A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL97328228A 1996-01-25 1997-01-17 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system PL328228A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602505A DE19602505A1 (en) 1996-01-25 1996-01-25 1- (pyrazol-4-indol-3-yl) piperidines
PCT/EP1997/000187 WO1997027186A1 (en) 1996-01-25 1997-01-17 1-pyrazol-3-yl-ethyl-4-indol-3-yl-piperidine used as medicine acting on the central nervous system

Publications (1)

Publication Number Publication Date
PL328228A1 true PL328228A1 (en) 1999-01-18

Family

ID=7783568

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97328228A PL328228A1 (en) 1996-01-25 1997-01-17 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system

Country Status (16)

Country Link
EP (1) EP0879234A1 (en)
JP (1) JP2000503972A (en)
KR (1) KR19990081970A (en)
CN (1) CN1209807A (en)
AR (1) AR005549A1 (en)
AU (1) AU715785B2 (en)
BR (1) BR9707467A (en)
CA (1) CA2244136A1 (en)
CZ (1) CZ231898A3 (en)
DE (1) DE19602505A1 (en)
HU (1) HUP9900980A2 (en)
NO (1) NO983439L (en)
PL (1) PL328228A1 (en)
SK (1) SK99298A3 (en)
WO (1) WO1997027186A1 (en)
ZA (1) ZA97572B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2219385T3 (en) * 1999-09-09 2004-12-01 H. Lundbeck A/S INDOLES REPLACED WITH 5-AMINOALQUILO AND 5-AMINOCARBONILO.
HK1045991B (en) 1999-11-10 2004-12-10 Takeda Pharmaceutical Company Limited 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
HK1052509B (en) 2000-08-14 2007-09-07 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazoles
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
PL369674A1 (en) * 2001-11-14 2005-05-02 Merck Patent Gmbh Pyrazole derivatives as psychopharmaceuticals
KR101009860B1 (en) 2005-10-11 2011-01-19 에프. 호프만-라 로슈 아게 Imidazo Benzodiazepines Derivatives
AU2006306497A1 (en) * 2005-10-24 2007-05-03 Janssen Pharmaceutica, N.V. 3-piperidin-4-yl-indole ORL-1 receptor modulators
TWI548630B (en) 2011-04-06 2016-09-11 Lg生命科學有限公司 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof
EP4218755A4 (en) * 2020-11-04 2024-03-27 Lg Chem, Ltd. Method for preparing crystalline particles of 1-(3-cyano-1-isopropyl-indole-5-yl)pyrazole-4-carboxylic acid, and pharmaceutical composition comprising same
IL326081A (en) * 2023-07-24 2026-03-01 Innovstone Therapeutics Ltd Receptor agonist, and preparation method therefor and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060816C3 (en) * 1970-12-10 1980-09-04 Merck Patent Gmbh, 6100 Darmstadt 4-Phenylpiperidine derivatives Process for their production and pharmaceutical preparations containing these compounds
DE2258033A1 (en) * 1972-11-27 1974-05-30 Merck Patent Gmbh 3-Heterocyclylalkyl-pyrazoles prodn. - by dehydrogenation or acid elimination from pyrazol(id)ines, useful as CNS depressants
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
US5045550A (en) * 1990-09-20 1991-09-03 Warner-Lambert Co. Substituted tetrahydropyridines as central nervous system agents
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine

Also Published As

Publication number Publication date
ZA97572B (en) 1997-08-04
HUP9900980A2 (en) 1999-07-28
EP0879234A1 (en) 1998-11-25
WO1997027186A1 (en) 1997-07-31
AU715785B2 (en) 2000-02-10
KR19990081970A (en) 1999-11-15
BR9707467A (en) 1999-07-20
CA2244136A1 (en) 1997-07-31
JP2000503972A (en) 2000-04-04
SK99298A3 (en) 1999-01-11
AR005549A1 (en) 1999-06-23
CN1209807A (en) 1999-03-03
DE19602505A1 (en) 1997-07-31
AU1443297A (en) 1997-08-20
NO983439D0 (en) 1998-07-24
CZ231898A3 (en) 1998-10-14
NO983439L (en) 1998-09-25

Similar Documents

Publication Publication Date Title
ZA979985B (en) N-substituted 2-cyanopyrrolidines.
HU9503402D0 (en) Neurokinin receptor antagonists
ZA977011B (en) Muscarinic antagonists.
ZA977969B (en) Reflux inhibitors.
GB9719141D0 (en) Stabilizer combination
HUP0000487A3 (en) Subsituted oximes derivatives useful as neurokinin antagonists
ZA97303B (en) Pyrido-fused thienyl- and furanyl-oxazolidinones
PL332593A1 (en) N-substituted azaheterocyclic compounds
CY2408B1 (en) Paroxetine controlled release compositions.
GB9605207D0 (en) Address block location
GB9605027D0 (en) Quinoxalinediones
HUP9904622A3 (en) 1,4-di-sustituted piperidines as muscarinic antagonists
HUP0202034A3 (en) Heterocyclic substituted aminoazacycles useful as central nervous system agents
ZA985875B (en) Azetidines.
PL342732A1 (en) 1-(heteroarylpropyl- or -prop-2-enyl)-4 benzylpiperidine as antagopnists nmda receptor
AP9600901A0 (en) Azetidines
AU2446297A (en) Substituted piperazines and piperidines as central nervous system agents
HRP970302B1 (en) Overvoltage sink
ZA972131B (en) Stabilizer combination.
PL328228A1 (en) 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidines as agents influencing the central nervous system
IL129121A0 (en) N-substituted azaheterocyclic compounds
PL334569A1 (en) Substituted 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine for treating the central nervous system
EP1017279A4 (en) Methods for regulating trka expression
AU4376997A (en) N-substituted azaheterocyclic compounds
HRP970094A2 (en) 1,4-dihydropyridine compounds